What to watch with Omega-3 Index and Darmgesundheit?

The Omega-3 Index measures the percentage of EPA and DHA in red blood cell membranes and is a validated biomarker for cardiovascular risk and systemic inflammation. Gut health (Darmgesundheit) involves microbiome composition, intestinal barrier integrity, and immune tolerance. Emerging evidence suggests omega-3 fatty acids can modulate the gut microbiota, increasing beneficial bacteria (e.g., Bifidobacterium, Lactobacillus) and reducing pro-inflammatory species. However, the evidence is mixed: human studies show associations but not consistent causality. MyBody-X offers separate tests for Omega-3 Index (blood spot) and gut health (stool microbiome). Combining them may provide insights into how omega-3 status relates to gut inflammation or dysbiosis. Caveats: The Omega-3 Index reflects long-term intake, not acute gut status. No direct diagnostic claim for GI diseases. If you have gastrointestinal symptoms, consult a gastroenterologist. Also, high-dose omega-3 supplements can interact with anticoagulants. The tests are lifestyle tools, not medical devices.